make life lively Meiji

Meiji Holdings Co., Ltd.

Japanese

  • about us

    About Us

    • Who We Are
    • President Message
    • Mission and Vision
    • Corporate Profile
    • History
    • R&D
      Food and Nutrition
      Pharmaceuticals
    • Quality
      Food and Nutrition
      Pharmaceuticals
  • products

    Products

    • Lineup
      Drinking Milk
      Yogurt
      Functional Yogurt
      Cheese
      Ice Cream
      Chocolate
      Whey Protein
      Infant Formula
      Beauty Supplement
      Enteral Formula and Nutritional Products
      Ethical Pharmaceuticals
      Agricultural Chemicals and Veterinary Drugs
    • Meiji Worldwide
      Meiji worldwide
  • investors

    Investors

    • 2018 Review
    • Our Businesses
    • Financial Performance
    • Business Plans
      2020 Medium-Term Business Plan
    • Governance
      Annual General Meeting
      Corporate Governance
      Business Risks
    • Results and Presentations
      Results
      Presentations
      DATA BOOK
      Integrated Reports
      R&D Pipeline
    • Stock Information
      Dividends
      Corporate Bonds and Ratings
      Analyst Coverage
    • M&A and Alliances
    • Investor FAQs
    • Disclosure Policy
    • Events
      Events Archive
    • ESG data
  • sustainability

    Sustainability

    • Healthier Lives
      Health and Nutrition
      Quality and Safety
    • Caring for the Earth
      Climate Change
      Circular Economy
      Water
      Biodiversity
    • A richer society
      Human Resources
      Society
    • Sustainable Procurement
    • Governance
      Corporate Governance
      Compliance
      Risk Management
    • CSR Management
    • Policies
    • Download Report
    • UN Agencies
    • ESG data
    • GRI Standard Table
    • Sustainability Video
  • news
  • home
  • news
  • 2019

News

Feb 19, 2019
HD Notice of the Establishment of a New Research Laboratory – Co-Creation Center
Feb 7, 2019
HD 【Presentation】Financial Results for the Third quarter of Fiscal Year Ending March 31, 2019
Feb 7, 2019
HD Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2019
Jan 18, 2019
PHARMA Meiji Seika Pharma and Toray Reach Exclusive License Agreement on Antipuritic Agent TRK-820 in Thailand and Indonesia
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Back To Top

share

  • share
  • share
  • share

print

Worldwide Locations

Copyright Meiji Holdings Co., Ltd. All rights reserved.

  • Privacy Policy
  • Terms and Conditions